Clinical significance of the CALLY index in patients with gastric cancer undergoing gastrectomy
- PMID: 39349360
- DOI: 10.1002/wjs.12357
Clinical significance of the CALLY index in patients with gastric cancer undergoing gastrectomy
Abstract
Background: The aim of this study was to elucidate the clinical impact of the CALLY index in patients with gastric cancer (GC) undergoing gastrectomy.
Methods: Between January 2014 and December 2020, 617 patients who underwent gastrectomy for GC at the Osaka City General Hospital were enrolled in this study. The CALLY index was calculated using the following formula: [albumin (g/dL) × lymphocytes (/μl)]/[CRP (mg/dL) × 104]. We compared the predictive value of four biomarkers [CALLY index, modified Glasgow prognostic score (mGPS), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR)] for short- and long-term outcomes and focused on the CALLY index to elucidate its clinical value.
Results: Receiver operating characteristic analysis showed that the area under the curve for the CALLY index was the highest among the four biomarkers. The 5-year overall survival (OS) and cancer-specific survival (CSS) rates in the low and the high CALLY groups were statistically significant. Multivariate analysis identified the CALLY index as an independent factor for OS and CSS but not NLR or PLR. The mGPS was an independent factor for OS but not for CSS in multivariate analysis. Regarding complications, only the CALLY index was an independent predictor of major complications (≧ Clavien-Dindo grade 3) in multivariate analysis but not others.
Conclusions: The CALLY index may have a clinical value in predicting OS, CSS, and major complications in GC patients undergoing gastrectomy.
Keywords: CALLY index; gastrectomy; gastric cancer; nutrition; prognostic factor.
© 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).
References
REFERENCES
-
- Bray, F., J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal. 2018. “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians 68(6): 394–424. https://doi.org/10.3322/caac.21492.
-
- Kakeji, Y., A. Takahashi, H. Hasegawa, H. Ueno, S. Eguchi, I. Endo, A. Sasaki, et al. 2020. “Surgical Outcomes in Gastroenterological Surgery in Japan: Report of the National Clinical Database 2011‐2018.” Annals of gastroenterological surgery 4(3): 250–274. https://doi.org/10.1002/ags3.12324.
-
- Berkel, A. E. M., B. C. Bongers, H. Kotte, P. Weltevreden, F. H. C. de Jongh, M. M. M. Eijsvogel, M. Wymenga, et al. 2022. “Effects of Community‐Based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery with High Risk for Postoperative Complications: Results of a Randomized Clinical Trial.” Annals of Surgery 275(2): e299–e306. https://doi.org/10.1097/sla.0000000000004702.
-
- Minnella, E. M., R. Awasthi, S. E. Loiselle, R. V. Agnihotram, L. E. Ferri, and F. Carli. 2018. “Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial.” JAMA Surg 153(12): 1081–1089. https://doi.org/10.1001/jamasurg.2018.1645.
-
- Müller, L., F. Hahn, A. Mähringer‐Kunz, F. Stoehr, S. J. Gairing, M. Michel, F. Foerster, et al. 2021. “Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.” Cancers 13(19): 5018. https://doi.org/10.3390/cancers13195018.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
